Podcasts about pcab

Visit learnAMAstyle.com to uplevel your writing and editing skills with free downloads on medical writing and editing. The FDA has approved vonoprazan (Voquenza) for treating non-erosive gastroesophageal reflux disease (GERD) in adults. Vonoprazan is an oral potassium-competitive acid blocker (PCAB) already approved for erosive esophagitis and Helicobacter pylori infection. PCABs are a new class of medicines that inhibit stomach acid secretion. Non-erosive GERD is the most common form of GERD, affecting around 45 million US adults, with about 15 million treated with prescription medication annually. Many patients remain dissatisfied with existing treatments, experiencing symptoms that affect their quality of life. The approval of vonoprazan was based on the Phalcon-Nerd-301 study, a Phase 3 trial showing it significantly reduced heartburn episodes and provided more heartburn-free days and nights compared to placebo. The trial included 772 adults with frequent heartburn, demonstrating vonoprazan's effectiveness over placebo. The FDA has granted fast track designation to ADI-270 for metastatic or advanced clear cell renal cell carcinoma (ccRCC) in patients who previously received an immune checkpoint inhibitor and a VEGF inhibitor. ADI-270 is a CD70-targeted gamma delta CAR T-cell therapy designed to enhance resilience to the tumor microenvironment. A phase 1/2 trial will evaluate ADI-270 in patients with confirmed ccRCC who have been previously treated. The primary endpoints are the incidence of dose-limiting toxicities and the proportion of treatment-emergent adverse effects. The FDA has granted Fast Track and Regenerative Medicine Advanced Therapeutic (RMAT) designations to Lomecel-B, an investigational MSC therapy for Alzheimer's disease (AD). Lomecel-B aims to address neurodegeneration in AD and showed positive results in the CLEAR MIND Phase 2a trial. Visit learnAMAstyle.com to uplevel your writing and editing skills with free downloads on medical writing and editing.

Proton pump inhibitors have long been the mainstay of treatment for gastroesophageal reflux disease (GERD), dating back to omeprazole (Prilosec)'s initial approval in 1989. However, the treatment landscape has undergone its first major changes in the past 30 years with the emergence of vonoprazan (Voquezna). A novel, first-in-class small molecule potassium-competitive acid blocker (PCAB), vonoprazan now boasts 3 US Food and Drug Administration (FDA) approvals across both erosive and non-erosive GERD. Less than a year after earning approval for the healing and maintenance of healing of all grades of erosive GERD as well as the relief of heartburn associated with erosive GERD, vonoprazan has also been approved for the treatment of heartburn in non-erosive GERD.

Visit learnAMAstyle.com for free downloads in writing in medicine and the life sciences.    The FDA has approved blinatumomab (Blincyto) for treating adult and pediatric patients one month or older with CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia (B-ALL) in the consolidation phase. This bispecific T-cell engager (BiTE®) therapy targets CD19 surface antigens on B cells, allowing T cells to recognize and eliminate malignant B cells. The approval was based on the Phase 3 E1910 trial showing improved overall survival with blinatumomab plus chemotherapy compared to chemotherapy alone.   The FDA has approved roflumilast cream 0.15% (Zorvye) for treating mild to moderate atopic dermatitis (AD) in patients aged 6 years and older. This steroid-free, once-daily topical treatment is a selective, highly potent phosphodiesterase 4 (PDE4) inhibitor designed for long-term disease control. The approval was based on phase 3 studies showing significant improvements in disease clearance, itch reduction, and overall skin condition compared to the vehicle group.   The FDA has approved a new 6mg single-dose prefilled syringe for faricimab-svoa (Vabysmo), facilitating easier administration for neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema (DME), and macular edema following retinal vein occlusion (RVO). Faricimab-svoa is a VEGF and Ang-2 inhibitor, now available in a ready-to-use format. This approval provides an alternative to the existing single-dose vial and is granted to Genentech.   The FDA is set to decide on OX124, a high-dose naloxone nasal rescue medication designed to reverse opioid overdoses, with the PDUFA date set for July 15, 2024. Developed by Orexo, OX124 offers rapid absorption, high bioavailability, and enhanced stability, addressing the critical need for potent rescue medications due to the high rate of synthetic opioid overdoses. If approved, OX124's launch is anticipated later in 2024.   The FDA accepted an NDA for vonoprazan (Voquezna) tablets for treating heartburn associated with Non-Erosive gastroesophageal reflux disease (GERD) in adults, with the PDUFA date set for July 19, 2024. Vonoprazan is a potassium-competitive acid blocker (PCAB) offering an alternative to traditional proton pump inhibitors (PPIs). Non-Erosive GERD, affecting 38 million U.S. adults, is characterized by reflux-related symptoms without esophageal mucosal erosions, impacting quality of life with symptoms like heartburn and chest pain.  

On this episode, I discuss the new medication vonoprazan and where it will likely be used in practice. Vonoprazan is from a brand new class of medication called "PCAB". I discuss this medication and its pharmacology in this podcast episode. Drug interactions and cost are the two major downsides of this medication that will likely limit its use compared to the PPIs. CYP3A4 inducers like rifampin, carbamazepine, and phenytoin should not be used with vonoprazan. They will reduce the effectiveness of vonoprazan.

Summary: Check out our free downloads at nascentmc.com: Implementing AMA Style – 8 Things to Get Right in Your Next Project Needs Assessments – 7 Essentials for Getting Funded Working With Your Medical Writer – 8 Ways to Get the Most out of Them See the full write ups for today's episode at nascentmc.com/podcast   Here are the highlights: Pembrolizumab (Keytruda) has received FDA approval for the treatment of metastatic biliary tract cancer, both in combination with chemotherapy and as a monotherapy. The approval is based on the positive outcomes of the KEYNOTE-966 trial, where patients receiving pembrolizumab plus chemotherapy demonstrated a statistically significant improvement in overall survival compared to those receiving a placebo with chemotherapy. Common adverse reactions included hematologic abnormalities, pyrexia, fatigue, cholangitis, and hepatic enzyme elevations. Approval was granted to Merck. Secukinumab (Cosentyx) has gained FDA approval for the treatment of moderate-to-severe hidradenitis suppurativa (HS), making it the first FDA-approved IL-17A inhibitor for this condition. Approval is based on results from the SUNSHINE and SUNRISE trials, showing significant improvements in response rates in HS patients treated with secukinumab compared to placebo. Ustekinumab-auub (Wezlana) has been granted FDA approval as an interchangeable biosimilar for Stelara, offering treatment options for multiple inflammatory diseases. It is indicated for moderate to severe plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis in adult patients, as well as pediatric patients with plaque psoriasis and psoriatic arthritis. Vonoprazan (Voquezna) has received FDA approval for the treatment of erosive esophagitis (GERD). As a potent potassium-competitive acid blocker (PCAB), it offers an alternative to proton pump inhibitors (PPIs). Approval is based on the PHALCON-EE study, where vonoprazan demonstrated noninferiority to lansoprazole in healing GERD. Abatacept (Orencia) has been expanded for use in pediatric patients aged 2 years and older to treat psoriatic arthritis. Originally approved for rheumatoid arthritis in adults in 2005, abatacept was also approved for adult psoriatic arthritis in 2017. Exa-cel, a CRISPR-based therapy developed by CRISPR Therapeutics and Vertex, is under FDA review for sickle cell disease. The advisory panel has found it safe for clinical use, with potential approval expected in December. Exa-cel aims to alleviate sickle cell symptoms through gene editing technology Intro and outro music Garden Of Love by Pk jazz Collective  

Marketing your pharmacy or small business is not something that is taught in pharmacy school or the medical field in general! Today, we hear from Bridget Hanna of Independent Edge Consulting. Bridget's passion for the profession and background in compounding pharmacy and marketing puts her in a very unique position to understand what is required when it comes to showcasing your business to your patients and providers. Bridget has been a Certified Pharmacy Technician since 2009. She has spent 12 years in independent pharmacy including working with a multi-location independent pharmacy as a compounding technician, marketer, social media manager and front end manager. Following her love and passion for independent pharmacy, compounding and marketing, she decided to go out on her own in 2019 and create Independent Edge Consulting.She enjoys sharing her knowledge and experience in independent pharmacy, compounding and marketing with her clients and on many platforms.Bridget truly believes that through education and marketing, independent pharmacies can provide limitless possibilities to their communities and to our world.Contact Independent Edge ConsultingWebsite: www.independentedgeconsulting.comFB: https://www.facebook.com/independentedgeIG: https://www.instagram.com/independent_edge_consulting/Email: bhanna@independentedgeconsulting.com Innovation Compounding Pharmacy Innovation Compounding is a nationwide PCAB-accredited sterile and nonsterile compounding pharmacyDisclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Support the show

Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States.[1]An estimated 26 million adults in the U.S. have diagnosed diabetes, 9.4 million adults have undiagnosed diabetes, and 91.8 million adults have prediabetes. [2]42.4% of adults are clinically obese. [3]Thankfully, with the recent developments of wearable technologies, it is now possible to prevent and treat common health conditions such as heart disease. In this podcast episode, Dr. Ram Cheruvu shares how these devices can be instrumental in detecting abnormal heart rhythms, monitoring glucose, and personalizing care. Listen as he shares his top three products to monitor and improve wellness!Guest Speaker BioDr. Ram Cheruvu, Pharm.D. is a pharmacist by education and a healer at heart. He has dedicated his life to helping others realize their full potential through functional medicine, guiding them towards clarity of purpose via high-performance coaching sessions. Dr. Ram founded Texas Functional Medicine, where he uses cutting-edge diagnostic tools to uncover the root cause of health concerns and employs a combination of interventions to eliminate triggers and restore proper function and balance.The Unlimited Potential ShowEvery week, Dr. Ram and Chris Morrell discuss their personal journeys to make self-development relatable and digestible. Each episode contains powerful habits and strategies to help listeners discover their unlimited potential.Podcast on iTunes, Spotify and AndroidInstagram @unlimitedpotentialshowFacebook @ramcheruvusterLinkedIn @doctorramAbout Innovation CompoundingInnovation Compounding is licensed as a 503A, compounding pharmacy, accredited by The Pharmacy Compounding Accreditation Board (PCAB®).Today, we support over 7,000 prescribers, 70,000+ patients, and annually provide 100,000+ prescriptions to 46 states across the U.S. We commit to individualized pharmaceutical care by being relentless in our drive for personalized medicine, compassionate toward our patients and doctors, and being a #WellnessAdvocate for our patients' lives and state of well being.Learn more about the work we do and how we can help to build your practice by visiting us online:Innovation Compounding Website Innovation Compounding Pharmacy Innovation Compounding is a nationwide PCAB-accredited sterile and nonsterile compounding pharmacyDisclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Support the show

Natalie and Coy talk with Dr. Jon Pritchett (PharmD, BCSCP), Program Director at the esteemed Accreditation Commission for Health Care (ACHC). Listen in as we discuss how the Pharmacy Compounding Accreditation Board (PCAB) got its start, where it is today, and ACHC's mission to help bridge prescribers and quality compounding partners. https://www.veterinarypharmacypodcast.com/

Episode Notes Matt Santelli of "Pierce County Aging and disability Resource Center" talks Medicare with Pierce County Association of the Blind. https://www.co.pierce.wa.us/1986/Aging-and-Disability-Resources Email: adrc@piercecountywa.gov  This content is provided by President Elect David Edick, and sponsored by PCAB and WCB Newsline. Pierce County Association of the Blind Tacoma, Pierce Co. President Cathy Wilson                         (253) 255-6747 c.wilson615@yahoo.com Meets third Saturday each month from 11 a.m. to 1 p.m. Location: TACID, 6315 S 19th St, Tacoma Website: http://pcabinfo.org Find out more at https://wcb-newsline-unleashed.pinecast.co

Join me for my conversation with Wedgewood Pharmacy's Dan Rowan, Vice President of Sales and Marketing, and  Jodi Donohue, Director of Marketing, to see how Wedgewood Pharmacy has proven that you can achieve high levels of empathy and meaningful customer communication no matter the size of your company. Wedgewood started as a local community pharmacy and has grown to one of the largest compounding pharmacies in the United States, all while maintaining the personalized touch they had from the beginning. To Wedgwood, empathy is about more than just being nice, it is about truly listening, utilizing design thinking, and seeing things from your customer's perspective, allowing everyone to truly live the company's mission and purpose. Key Takeaways:No matter how big you get, you need to keep checking in with your customers on a regular basis and keep the feedback loops open. Make the time within your own company to just listen. You can achieve empathy and customer communication at scale and be wildly successful while doing so! "If you really listen to your customers, and your internal and external stakeholders, you can drive an incredible organization." —  Dan Rowan About Wedgewood Pharmacy: Wedgewood Pharmacy is the largest 503A animal-health compounding pharmacy in the U.S. and has also served the human-health market since its founding in 1980. Compounded medications are preparations customized to the unique needs of a patient. They are created and prepared by specially trained pharmacists and pharmacy technicians in state-regulated facilities when mass-manufactured drugs are not, according to the prescriber, available or are not appropriate for a patient.  In its 40 years, Wedgewood Pharmacy has grown from a local community pharmacy to become one of the largest compounding pharmacies in the United States; it is the leading pharmacy in animal health. Wedgewood Pharmacy serves more than 50,000 prescribers and hundreds of thousands of patients throughout the U.S. every year. George (late) and Lucy Malmberg, both pharmacists, purchased Wedgewood Pharmacy in 1981; the pharmacy was founded in 1980. In June 2016, New Harbor Capital, became the majority shareholder of the company. In July 2018, the company acquired Diamondback Drugs, Scottsdale, Arizona. In 2020, the company began production at Wedgewood Connect, an FDA-registered 503B Outsourcing Facility, in San Jose, California. Wedgewood Pharmacy is accredited by the Pharmacy Compounding Accreditation Board (PCAB®) for compliance with PCAB and other nationally recognized compounding standards. PCAB was formed by eight of the nation's leading pharmacy associations and is a service of Accreditation Commission for Health Care. As a third-party accreditation organization, PCAB has developed the highest national standards against which providers are measured to demonstrate their ability to effectively and efficiently deliver quality compounded medications to consumers. Wedgewood Pharmacy employs more than 650 people in its state-of-the-art compounding pharmacies in Swedesboro, New Jersey and Scottsdale, Arizona, in its Wedgewood Connect 503B Outsourcing Facility in San Jose, California, and its Wildlife Pharmaceuticals/ZooPharm facilities in Colorado and Wyoming  Connect with Wedgewood, Dan Rowan, and Jodi Donohue:  Website: WedgewoodPharmacy.comFacebook: facebook.com/WedgewoodPetRxTwitter: twitter.com/wedgewoodpetrxDan Rowan on LinkedIn: linkedin.com/in/danrowanJodi Donohue on LinkedIn: linkedin.com/in/jodi-donohue-41a4252  Don't forget to download your free guide! Discover The 5 Business Benefits of Empathy: http://red-slice.com/business-benefits-empathy  Connect with Maria: Get the podcast and book: TheEmpathyEdge.comLearn more about Maria's brand strategy work and books: Red-Slice.comHire Maria to speak at your next event: Red-Slice.com/Speaker-Maria-RossLinkedIn: Maria RossInstagram: @redslicemariaTwitter: @redsliceFacebook: Red Slice

Join me for my conversation with Wedgewood Pharmacy's Dan Rowan, Vice President of Sales and Marketing, and  Jodi Donohue, Director of Marketing, to see how Wedgewood Pharmacy has proven that you can achieve high levels of empathy and meaningful customer communication no matter the size of your company. Wedgewood started as a local community pharmacy and has grown to one of the largest compounding pharmacies in the United States, all while maintaining the personalized touch they had from the beginning. To Wedgwood, empathy is about more than just being nice, it is about truly listening, utilizing design thinking, and seeing things from your customer's perspective, allowing everyone to truly live the company's mission and purpose. Key Takeaways:No matter how big you get, you need to keep checking in with your customers on a regular basis and keep the feedback loops open. Make the time within your own company to just listen. You can achieve empathy and customer communication at scale and be wildly successful while doing so! "If you really listen to your customers, and your internal and external stakeholders, you can drive an incredible organization." —  Dan Rowan About Wedgewood Pharmacy: Wedgewood Pharmacy is the largest 503A animal-health compounding pharmacy in the U.S. and has also served the human-health market since its founding in 1980. Compounded medications are preparations customized to the unique needs of a patient. They are created and prepared by specially trained pharmacists and pharmacy technicians in state-regulated facilities when mass-manufactured drugs are not, according to the prescriber, available or are not appropriate for a patient.  In its 40 years, Wedgewood Pharmacy has grown from a local community pharmacy to become one of the largest compounding pharmacies in the United States; it is the leading pharmacy in animal health. Wedgewood Pharmacy serves more than 50,000 prescribers and hundreds of thousands of patients throughout the U.S. every year. George (late) and Lucy Malmberg, both pharmacists, purchased Wedgewood Pharmacy in 1981; the pharmacy was founded in 1980. In June 2016, New Harbor Capital, became the majority shareholder of the company. In July 2018, the company acquired Diamondback Drugs, Scottsdale, Arizona. In 2020, the company began production at Wedgewood Connect, an FDA-registered 503B Outsourcing Facility, in San Jose, California. Wedgewood Pharmacy is accredited by the Pharmacy Compounding Accreditation Board (PCAB®) for compliance with PCAB and other nationally recognized compounding standards. PCAB was formed by eight of the nation's leading pharmacy associations and is a service of Accreditation Commission for Health Care. As a third-party accreditation organization, PCAB has developed the highest national standards against which providers are measured to demonstrate their ability to effectively and efficiently deliver quality compounded medications to consumers. Wedgewood Pharmacy employs more than 650 people in its state-of-the-art compounding pharmacies in Swedesboro, New Jersey and Scottsdale, Arizona, in its Wedgewood Connect 503B Outsourcing Facility in San Jose, California, and its Wildlife Pharmaceuticals/ZooPharm facilities in Colorado and Wyoming  Connect with Wedgewood, Dan Rowan, and Jodi Donohue:  Website: WedgewoodPharmacy.comFacebook: facebook.com/WedgewoodPetRxTwitter: twitter.com/wedgewoodpetrxDan Rowan on LinkedIn: linkedin.com/in/danrowanJodi Donohue on LinkedIn: linkedin.com/in/jodi-donohue-41a4252  Don't forget to download your free guide! Discover The 5 Business Benefits of Empathy: http://red-slice.com/business-benefits-empathy  Connect with Maria: Get the podcast and book: TheEmpathyEdge.comLearn more about Maria's brand strategy work and books: Red-Slice.comHire Maria to speak at your next event: Red-Slice.com/Speaker-Maria-RossLinkedIn: Maria RossInstagram: @redslicemariaTwitter: @redsliceFacebook: Red Slice

Listen as President and CEO of Innovation Compounding, Shawn Hodges, PharmD. discusses the ways that Innovation Compounding Pharmacy is helping combat the COVID-19 pandemic. He discusses what the pharmacy is doing for providers, pharmacists, patients, employees, and local businesses as an essential healthcare facility.www.innovationcompounding.com#pharmacy #covid #compounding #covid19 #hydroxychloroquine #zinc #virus #handsanitizer #azithromycin #health #kennesaw #healthcare #cobbcounty #PCAB #pharmacists #healthcare #frontlineSupport the show

Natalie and Coy place a long distance call with one of the first ever PCAB accredited veterinary pharmacies in the nation.  Erik Clausen, COO of Golden Gate Pharmacy in the greater bay area of California, sits down for a reflection on the evolution of veterinary pharmacy, regulations, and the vital role pharmacies play as the bridge between our veterinary partners and the pet parents we assist.  Listen as Eric defines the tenants of community pharmacy for veterinary medicine- how they operate in a perpetual state of emergency with both pandemics and wildfires ever knocking at their doors but continue to do what they do in service to our patients with a smile and open heart.

Natalie and Coy journey to the city of brotherly love to discuss all things compounding with the top community pharmacy in Philly! Listen as they discuss PCAB accreditation, pandemic challenges, and expert veterinary support with Dr. Jack Korbutov, owner of The Art of Medicine. Jack, along with Dr. Young, serves as a fellow of the American College of Veterinary Pharmacists (ACVP).

Michelle is a graduate of University of Washington 1987 with bachelor of science in Pharmacy. She holds a fellowship with American College of Apothecaries and American College of Veterinary Pharmacists. Michelle has worked in Long-term care, hospital based and retail pharmacies in the Puget Sound area. Michelle, worked at Skagit Valley Hospital, Hilltop Pharmacy and Holland Drug before starting a consulting business. In 2007, became an in-home medication therapy manager for COPES clients in Skagit, Whatcom, And Island counties. Also served ambulatory surgery centers as a pharmacist consultant in Skagit and Whatcom counties.  2011 opened the doors for Makers Compounding Pharmacy where medications are made by hand for specific patient needs. Compounding for human and veterinary customers is a privilege, according to Michelle. August 2015 a Hallmark store was added to the retail area. In March 2017, the ultimate goal is achieving national Accreditation through PCAB became a reality.

Compounding pharmacies: SO essential to the FxMed clinician’s toolkit. Compounding individualized prescriptions are at the heart of what we do, and on this podcast of New Frontiers, I am delighted to talk to Michelle Violi, Pharm. D, of Women’s International Pharmacy. Located in Wisconsin and Arizona, but serving clinicians and patients everywhere, WIP has been compounding bioidentical hormones for decades. Join our conversation, where we cover the background of WIP, their commitment to education (patients and clinicians; how to access), regulation of compounding pharmacies (its rather extraordinary), how to pick a good compounding pharmacy (check for PCAB status), and of course, we talk about hormones, too. Listen and give us a review on iTunes, or wherever you listen to New Frontiers! ~DrKF

This week we talk with Rad Dillon. He is a pharmacist and certified surveyor and consultant for the Accreditation Commission for Health Care with a lot of experience performing PCAB accreditation audits. Rad also has experience in writing Standard Operating Procedures and pharmacy management. He's also attained the American Society for Quality's Quality Auditing (CQA) and Quality Management/Operational Excellence (CMQ OE) certifications. Sign up for updates from PharmacyInspection.com: [mc4wp_form id="14886"] If you like the podcast follow us on twitter @PharmacyInspect and share the podcast with those who might find it helpful. We're just getting warmed up; there's SO many more topics to cover! Stay tuned for what's to come! Thanks for listening. Do you have a question or comment for the show? Leave us a VOICEMAIL, right on our site! --- Support this podcast: https://anchor.fm/pharmacy-inspection/support

This week Seth & Bryan talks with Rad Dillon. He is a pharmacist and certified surveyor and consultant for the Accreditation Commission for Health Care with a lot of experience performing PCAB accreditation audits. Rad also has experience in writing Standard Operating Procedures and pharmacy management. He's also attained the American Society for Quality's Quality Auditing (CQA) and Quality Management/Operational Excellence (CMQ OE) certifications. Sign up for updates from PharmacyInspection.com: https://pharmacyinspection.com/pharmacy-inspection-podcast-episode-10-rad-dillon/ See omnystudio.com/listener for privacy information.

This week Seth & Bryan talks with Rad Dillon. He is a pharmacist and certified surveyor and consultant for the Accreditation Commission for Health Care with a lot of experience performing PCAB accreditation audits. Rad also has experience in writing Standard Operating Procedures and pharmacy management. He’s also attained the American Society for Quality’s Quality Auditing (CQA) and Quality Management/Operational Excellence (CMQ OE) certifications. Sign up for updates from PharmacyInspection.com: https://pharmacyinspection.com/pharmacy-inspection-podcast-episode-10-rad-dillon/

This week we talk with Rad Dillon. He is a pharmacist and certified surveyor and consultant for the Accreditation Commission for Health Care with a lot of experience performing PCAB accreditation audits. Rad also has experience in writing Standard Operating Procedures and pharmacy management. He's also attained the American Society for Quality's Quality Auditing (CQA) and Quality Management/Operational Excellence (CMQ OE) certifications. Sign up for updates from PharmacyInspection.com: [mc4wp_form id="14886"] If you like the podcast follow us on twitter @PharmacyInspect and share the podcast with those who might find it helpful. We're just getting warmed up; there's SO many more topics to cover! Stay tuned for what's to come! Thanks for listening. Do you have a question or comment for the show? Leave us a VOICEMAIL, right on our site!   

This week we talk with Rad Dillon. He is a pharmacist and certified surveyor and consultant for the Accreditation Commission for Health Care with a lot of experience performing PCAB accreditation audits. Rad also has experience in writing Standard Operating Procedures and pharmacy management. He's also attained the American Society for Quality's Quality Auditing (CQA) and Quality Management/Operational Excellence (CMQ OE) certifications. Sign up for updates from PharmacyInspection.com: [mc4wp_form id="14886"] If you like the podcast follow us on twitter @PharmacyInspect and share the podcast with those who might find it helpful. We're just getting warmed up; there's SO many more topics to cover! Stay tuned for what's to come! Thanks for listening. Do you have a question or comment for the show? Leave us a VOICEMAIL, right on our site!   

PCAB Sterile and Non-Sterile Compounding Workshop July 25-26, 2017 Fairleigh Dickinson School of Pharmacy and Health Sciences Florham Park, NJ The PCAB Sterile and Non-Sterile Compounding Pharmacy workshop provides pharmacy personnel with a comprehensive overview of the accreditation process and a standard-by-standard review of the requirements for sterile and non-sterile compounding. The two-day course is conducted with a personalized approach that delivers valuable insight into the accreditation process. This workshop will offer 8.75 CEs. During the workshop, an AU Clinical Educator and Surveyor will provide participants with: Hands-on training for using the take-home ACHC Accreditation Guide to Success workbook, a program-specific and comprehensive tool that offers guidance on the meanings and requirements of each ACHC Accreditation Standard Resources that contain audit tools and hints How to prepare a PCAB-compliant PI program A take-home USP Gap Analysis Tool Essential components for accreditation preparation Best practices for a successful on-site survey Round table discussions, networking opportunities,and the ability to add submissions for round table topics Each attendee will receive the ACHC Accreditation Guide to Success workbook for FREE, which will be used as the primary learning instrument during the course. This workbook serves as a valuable reference tool for achieving or maintaining accreditation. Unless otherwise noted, workshops are held at ACHC's Corporate Headquarters in Cary, NC (a five-minute drive from Raleigh-Durham International airport - RDU). Learning Objectives: Review compounding standards Establish expectations for survey day and strategies for survey success Discuss compliance topics and Performance Improvement (PI) Learn how to utilize the ACHC Accreditation Guide to Success workbook to ensure ongoing compliance See omnystudio.com/listener for privacy information.

PCAB Sterile and Non-Sterile Compounding Workshop July 25-26, 2017 Fairleigh Dickinson School of Pharmacy and Health Sciences Florham Park, NJ The PCAB Sterile and Non-Sterile Compounding Pharmacy workshop provides pharmacy personnel with a comprehensive overview of the accreditation process and a standard-by-standard review of the req

ACHC/PCAB join with VGM, Attentus to discuss newest standards for compounding pharmacies Pharmacy Compounding Accreditation Board (PCAB), a service of Accreditation Commission for Health Care (ACHC), along with Attentus Medical Sales, Inc., a pharmacy and medical products manufacturer, and VGM and Associates, a member services organization serving the home medical equipment industry, today announced plans to host a series of free webinars to discuss the implications of recently-released hazardous drug safety standards by the United States Pharmacopeia convention, USP 800. "The pharmacy compounding industry is undergoing some significant regulatory changes," said José Domingos, ACHC CEO, referring specifically to the newly-released USP 800 as well as revisions to the existing standard for sterile compounding, USP 797. "I applaud Attentus and VGM for coming forward to recognize the need and support the information needs of compounding pharmacies." "Our home infusion and compounding pharmacies are under continuous regulatory and pricing pressures today so they are asking for direct answers and solutions for these changes to USP 800," said Tom Tucker V.P. Sales and Marketing, Attentus Medical Sales. "We see these webinars as a way to help our pharmacies break down these changes to manageable tasks." "VGM seeks out solutions to address challenges that its membership faces," said Frank Geiger, VGM Director Home Infusion. "USP 800 is going to be a complex change in the way business is conducted. VGM will take a leadership role in making sure our members have the information and support they need to be successful." The schedule for the webinars is as follows:     May 3rd – 4:00 PM EST    (Sterile)     May 5th – 4:00 PM EST    (Non-Sterile)     May 9th – 1:00 PM EST     (Non-Sterile)     May 10th – 4:00 PM EST (Sterile) Interested parties can find more information and register for these webinars at: https://attendee.gotowebinar.com/register/7738522639425900546. As a leading accreditation organization, ACHC is committed to providing educational resources that facilitate continuous compliance. Through its educational division, Accreditation University, ACHC offers a range of resources designed to help pharmacies achieve and maintain compliance including workbooks, workshops, and compliance checklists as well as customized consulting options. ACHC is a non-profit accreditation organization that has stood as a symbol of quality and excellence since 1986. The organization has CMS Deeming Authority for Home Health, Hospice, and DMEPOS and a Quality Management System that is certified to ISO 9001:2008. ACHC is the provider's choice for accreditation because of its personal Accreditation Advisors, relevant and realistic standards, competitive pricing, and a friendly, consultative approach to accreditation. Accreditation by ACHC reflects an organization's dedication and commitment to meeting standards that facilitate a higher level of performance and patient care. As a service of ACHC, PCAB is the currently the only comprehensive accreditation solution for compounding pharmacies wishing to demonstrate compliance with USP standards. For more information on ACHC's accreditation programs, or to download ACHC accreditation standards, please visit http://www.achc.org or contact them at customerservice@achc.org or 855-937-2242. VGM Home Infusion is powered by the VGM Group, Inc., a national leader in providing business solutions for diverse industries including health care, insurance and golf. VGM provides a complete line of business solutions and purchasing contracts to more than 25,000 companies throughout the United States and Canada. From group purchasing contracts to continuing education; from audit, appeals and medical review consultation to market data, patient referrals and marketing services, VGM Home Infusion can help members grow revenue, manage expenses and remain compliant. Attentus Medical Sales, Inc, based in Houston TX, is a leading nationwide manufacturer and distributor of medical products specializing in cold chain packaging, USP 797 & USP 800 compliance products, infusion pumps and supplies, back packs and fanny packs for portable infusion pumps, and various other medical supplies. Attentus Medical services the compounding pharmacy, home infusion, specialty pharmacy, and HME markets. Founded in 2003, Attentus has experienced tremendous growth every year with a continuous focus on developing solutions for our customer's ever changing needs in this dynamic marketplace. We strive to provide the highest levels of personal attention and consideration to the client. Each client will have a dedicated sales rep and customer service rep as well as have their phone call answered by a live person every time. We are dedicated to providing a high level service and the consultative support for all your business needs. http://www.attentusmedical.com See omnystudio.com/listener for privacy information.

The Pharmacy Podcast Show - has partnered with Diplomat Specialty Pharmacy to bring to our pharmacy industry listeners our Specialty Pharmacy segment dedicated to the important vertical that is SPECIALTY PHARMACY.   About Diplomat Specialty Pharmacy:   About Diplomat Diplomat serves patients and physicians in all 50 states as the nation's largest independent specialty pharmacy. Headquartered in Flint, Mich., the company focuses on medication management programs for people with specialized, long-term medical needs, including cancer, HIV and multiple sclerosis — always focused on increasing adherence and improving patients' outcomes. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients, and the rest falls into place.” Today, that tradition continues. In addition to operating as a specialty pharmacy, the company provides back-end services to retailers and hospital pharmacies looking to enter the specialty market. In managed care, it offers specialty coverage to more than 12 million lives nationwide. For five years running, Diplomat has been counted among the Inc. 500|5000 fastest-growing companies in the country; within the last three years, its numbers more than doubled. In 2012 alone, the company was named a Top Work Place by the Detroit Free Press, and its CEO, Phil Hagerman, was named by MLive Media Group as one of 13 Michiganders to Watch. Meanwhile, Diplomat's patient satisfaction rates lay between 98 and 99 percent, and the company earned $1.1 billion in annual revenue. Diplomat is accredited by URAC, PCAB, VAWD, ASHP and ACHC. Learn more at diplomatpharmacy.com. See omnystudio.com/listener for privacy information.